Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Nelfinavir monotherapy increases naïve T-cell numbers in HIV-negative healthy young adults.

Rizza SR, Tangalos EG, McClees MD, Strausbauch MA, Targonski PV, McKean DJ, Wettstein PJ, Badley AD.

Front Biosci. 2008 Jan 1;13:1605-9.

2.

CD28 ligation costimulates cell death but not maturation of double-positive thymocytes due to defective ERK MAPK signaling.

Graham DB, Bell MP, Huntoon CJ, Griffin MD, Tai X, Singer A, McKean DJ.

J Immunol. 2006 Nov 1;177(9):6098-107.

4.

Ly9 (CD229)-deficient mice exhibit T cell defects yet do not share several phenotypic characteristics associated with SLAM- and SAP-deficient mice.

Graham DB, Bell MP, McCausland MM, Huntoon CJ, van Deursen J, Faubion WA, Crotty S, McKean DJ.

J Immunol. 2006 Jan 1;176(1):291-300. Erratum in: J Immunol. 2006 Mar 15;176(6):3841.

5.

Increased thymic output in HIV-negative patients after antiretroviral therapy.

Graham DB, Bell MP, Huntoon CJ, Weaver JG, Hawley N, Badley AD, McKean DJ.

AIDS. 2005 Sep 23;19(14):1467-72.

PMID:
16135899
6.

Dynamin 2 regulates T cell activation by controlling actin polymerization at the immunological synapse.

Gomez TS, Hamann MJ, McCarney S, Savoy DN, Lubking CM, Heldebrant MP, Labno CM, McKean DJ, McNiven MA, Burkhardt JK, Billadeau DD.

Nat Immunol. 2005 Mar;6(3):261-70. Epub 2005 Feb 6.

PMID:
15696170
7.

Augmentation of T cell levels and responses induced by androgen deprivation.

Roden AC, Moser MT, Tri SD, Mercader M, Kuntz SM, Dong H, Hurwitz AA, McKean DJ, Celis E, Leibovich BC, Allison JP, Kwon ED.

J Immunol. 2004 Nov 15;173(10):6098-108.

8.

Selective inhibition of inflammatory gene expression in activated T lymphocytes: a mechanism of immune suppression by thiopurines.

Thomas CW, Myhre GM, Tschumper R, Sreekumar R, Jelinek D, McKean DJ, Lipsky JJ, Sandborn WJ, Egan LJ.

J Pharmacol Exp Ther. 2005 Feb;312(2):537-45. Epub 2004 Sep 23.

PMID:
15388785
9.

Direct transcriptional regulation of RelB by 1alpha,25-dihydroxyvitamin D3 and its analogs: physiologic and therapeutic implications for dendritic cell function.

Dong X, Craig T, Xing N, Bachman LA, Paya CV, Weih F, McKean DJ, Kumar R, Griffin MD.

J Biol Chem. 2003 Dec 5;278(49):49378-85. Epub 2003 Sep 24.

10.

Distinctive dendritic cell modulation by vitamin D(3) and glucocorticoid pathways.

Xing N, L Maldonado ML, Bachman LA, McKean DJ, Kumar R, Griffin MD.

Biochem Biophys Res Commun. 2002 Sep 27;297(3):645-52.

PMID:
12270143
11.

Role of nuclear factor-kappa B in the activation of alveolar macrophages by fungal beta-glucans.

Vassallo R, Huntoon C, McKean DJ, Limper AH.

J Eukaryot Microbiol. 2001;Suppl:160S. No abstract available.

PMID:
11906043
12.
13.

Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo.

Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R.

Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6800-5. Epub 2001 May 22.

14.
15.

Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs.

Griffin MD, Lutz WH, Phan VA, Bachman LA, McKean DJ, Kumar R.

Biochem Biophys Res Commun. 2000 Apr 21;270(3):701-8.

PMID:
10772887
16.

Inhibition of interleukin-1-stimulated NF-kappaB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity.

Egan LJ, Mays DC, Huntoon CJ, Bell MP, Pike MG, Sandborn WJ, Lipsky JJ, McKean DJ.

J Biol Chem. 1999 Sep 10;274(37):26448-53.

19.

Signaling through delta opioid receptors on murine splenic T cells and stably transfected Jurkat cells.

Sharp BM, McKean DJ, McAllen K, Shahabi NA.

Ann N Y Acad Sci. 1998 May 1;840:420-4.

PMID:
9629268
20.
21.

Dual signal transduction through delta opioid receptors in a transfected human T-cell line.

Sharp BM, Shahabi NA, Heagy W, McAllen K, Bell M, Huntoon C, McKean DJ.

Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8294-9.

22.

Interleukin-1 signal transduction.

Bankers-Fulbright JL, Kalli KR, McKean DJ.

Life Sci. 1996;59(2):61-83. Review.

PMID:
8699924
23.
24.

Truncated MHC class II cytoplasmic and transmembrane domains: effect on plasma membrane expression.

Wade WF, Khrebtukova I, Schreiber KL, McKean DJ, Wade TK.

Mol Immunol. 1995 Apr;32(6):433-46.

PMID:
7753052
25.

Molecular mechanisms that control expression of the B lymphocyte antigen receptor complex.

Grupp SA, Mitchell RN, Schreiber KL, McKean DJ, Abbas AK.

J Exp Med. 1995 Jan 1;181(1):161-8.

26.

IL-1 receptor and TCR signals synergize to activate NF-kappa B-mediated gene transcription.

McKean DJ, Bell M, Huntoon C, Rastogi S, Van Norstrand M, Podzorski R, Nilson A, Paya C.

Int Immunol. 1995 Jan;7(1):9-20.

PMID:
7718519
27.

Tumor localization and therapeutic potential of an antitumor-anti-CD3 heteroconjugate antibody in human renal cell carcinoma xenograft models.

Zhu Z, Ghose T, Lee SH, Fernandez LA, Kerr LA, Donohue JH, McKean DJ.

Cancer Lett. 1994 Oct 28;86(1):127-34.

PMID:
7954349
29.

Substitution of class II alpha chain polymorphic residues defines location of A alpha k serologic epitopes and alters association between alpha beta and Ii polypeptides.

Wei BY, Schreiber K, Buerstedde JM, Bell M, Nilson A, Huntoon C, Chase C, McKean DJ.

Int Immunol. 1994 Feb;6(2):297-305.

PMID:
7512376
30.

Class II histocompatibility molecules associate with calnexin during assembly in the endoplasmic reticulum.

Schreiber KL, Bell MP, Huntoon CJ, Rajagopalan S, Brenner MB, McKean DJ.

Int Immunol. 1994 Jan;6(1):101-11.

PMID:
8148318
31.

Murine T helper cell-2 lymphocytes express type I and type II IL-1 receptors, but only the type I receptor mediates costimulatory activity.

McKean DJ, Podzorski RP, Bell MP, Nilson AE, Huntoon CJ, Slack J, Dower SK, Sims J.

J Immunol. 1993 Oct 1;151(7):3500-10.

PMID:
8376789
32.

Effects of p56lck deficiency on the growth and cytolytic effector function of an interleukin-2-dependent cytotoxic T-cell line.

Karnitz L, Sutor SL, Torigoe T, Reed JC, Bell MP, McKean DJ, Leibson PJ, Abraham RT.

Mol Cell Biol. 1992 Oct;12(10):4521-30.

34.

Functional effects of N-linked oligosaccharides located on the external domain of murine class II molecules.

Wei BY, Buerstedde JM, Bell M, Chase C, Nilson A, Browne A, Pease L, McKean DJ.

J Immunol. 1991 Apr 1;146(7):2358-66.

PMID:
1706396
35.

Anti-tumor X anti-lymphocyte heteroconjugates augment colon tumor cell lysis in vitro and prevent tumor growth in vivo.

Nelson H, Ramsey PS, McKean DJ, Dozois RR, Donohue JH.

Dis Colon Rectum. 1991 Feb;34(2):140-7.

PMID:
1825192
36.

The contribution of beta-strand residues to serologic epitopes on the A beta k polypeptide.

Beck BN, Nilson AE, Bell MP, Chase CG, McKean DJ.

Immunogenetics. 1991;33(5-6):409-12. No abstract available.

PMID:
1711011
37.

The role of Ia in the formation of a T cell antigen-recognition complex.

Esch TR, McKean DJ, Thomas DW.

J Immunol. 1990 Dec 15;145(12):3979-84.

PMID:
2258604
38.
39.
40.

Effector function of lymphokine-activated killer cells and cytotoxic T lymphocytes in ovarian epithelial carcinoma.

Lentz SS, Kovach JS, McKean DJ, Wieand HS, Podratz KC.

Gynecol Oncol. 1990 Aug;38(2):191-6.

PMID:
2387535
41.

Heteroconjugate antibody-directed killing of autologous human renal carcinoma cells by in vitro-activated lymphocytes.

Kerr L, Huntoon C, Donohue J, Leibson PJ, Bander NH, Ghose T, Luner SJ, Vessella R, McKean DJ.

J Immunol. 1990 May 15;144(10):4060-7.

PMID:
2139677
42.

Anti-tumor x anti-CD3 heteroconjugates direct human peripheral blood lymphocytes to lyse colon tumor cells.

Nelson H, McKean DJ, Kerr LA, Donohue JH.

J Surg Res. 1990 Apr;48(4):284-90.

PMID:
2338812
43.

Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.

Ruegemer JJ, Ho SN, Augustine JA, Schlager JW, Bell MP, McKean DJ, Abraham RT.

J Immunol. 1990 Mar 1;144(5):1767-76.

PMID:
2407783
44.

Mapping T cell receptor epitopes on the A beta polypeptide.

Beck BN, McKean DJ.

Immunol Res. 1990;9(1):47-56. Review. No abstract available.

PMID:
1689364
45.

Evidence of eosinophil granule major basic protein in human placenta.

Wasmoen TL, McKean DJ, Benirschke K, Coulam CB, Gleich GJ.

J Exp Med. 1989 Dec 1;170(6):2051-63.

46.

Identification of I-A beta-chain residues critical for T cell recognition of peptide antigens.

Esch TR, McKean DJ, Thomas DW.

Cell Immunol. 1989 Oct 1;123(1):226-35.

47.

Lymphokine-activated killer (LAK) cell activity in tumor-infiltrating lymphocytes from non-small cell lung cancer.

Pisani RJ, Krco CJ, Wold LE, McKean DJ.

Am J Clin Pathol. 1989 Oct;92(4):435-46.

PMID:
2552792
48.

Human eosinophil-derived neurotoxin and eosinophil protein X are likely the same protein.

Slifman NR, Venge P, Peterson CG, McKean DJ, Gleich GJ.

J Immunol. 1989 Oct 1;143(7):2317-22.

PMID:
2506283
49.

Phenotypic and functional characteristics of mononuclear cells in ovarian carcinoma tumors.

Lentz SS, McKean DJ, Kovach JS, Podratz KC.

Gynecol Oncol. 1989 Aug;34(2):136-40.

PMID:
2787770
50.

I-Ak polymorphisms define a functionally dominant region for the presentation of hen egg lysozyme peptides.

Rosloniec EF, Vitez LJ, Beck BN, Buerstedde JM, McKean DJ, Landais D, Benoist C, Mathis D, Freed JH.

J Immunol. 1989 Jul 1;143(1):50-8. Erratum in: J Immunol 1989 Nov 1;143(9):3104.

PMID:
2786533

Supplemental Content

Loading ...
Support Center